WADHANE JITENDRA (SVP, Chief Accounting Officer) received a stock award from PYXIS ONCOLOGY, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 3/28/2023ACC: 0001209191-23-021411
Officer· SVP, Chief Accounting Officer
Since Aug 2022
+74.39K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
231.65K acquired · 157.26K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+29.39K
Price / share
—
Trade value
—
% of position
33.2%
3/24/2023
88.65K→118.04K
Common Stock
Direct
Shares
+45K
Price / share
—
Trade value
—
% of position
103.1%
3/24/2023
43.65K→88.65K
Total
Net shares
+74.39K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/24/2023 | A · Award | +29.39K | — | — | 33.2% | 88.65K | 118.04K |
| Common Stock Direct | 3/24/2023 | A · Award | +45K | — | — | 103.1% | 43.65K | 88.65K |
| Total | +74.39K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to buy)
Direct
Converts to
Common Stock
157.26K shares
Shares
−157.26K
Strike price
8.71
Held after
0.00
Exercisable
—
3/24/2023
Stock Option (Right to buy)
Direct
Converts to
Common Stock
157.26K shares
Shares
+157.26K
Strike price
2.21
Held after
157.26K
Exercisable
—
3/24/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock157.26K shares | 3/24/2023 | D · Disposition | −157.26K | 8.71 | — | 0.00 |
| Stock Option (Right to buy) Direct | Common Stock157.26K shares | 3/24/2023 | A · Award | +157.26K | 2.21 | — | 157.26K |